Healthcare -
Biotechnology - NASDAQ - US
$ 6.94
-29.1 %
$ 317 M
Market Cap
-6.35
P/E
CAPR - REVENUE
Revenue CAPR - Capricor Therapeutics, Inc.
22.3 M
LAST VALUE
195.59%
2 YEAR CAGR
85.83%
5 YEAR CAGR
16.62%
10 YEAR CAGR